USD 10.05
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| EHTH | 1.6 | 4.8 | 24.2 | 119.0 | 123.3 | 71.8 | -56.2 | -89.8 | -6.1 | -56.1 |
| S&P 500 | 1.0 | 3.7 | 2.1 | 2.3 | 8.2 | 25.4 | 31.0 | 80.6 | 196.5 | 33856.2 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | EHTH |
| name | eHealth, Inc. |
| price | 10.05 |
| changes percentage | 1.6178 |
| change | 0.16 |
| day low | 9.75 |
| day high | 10.2499 |
| year high | 10.68 |
| year low | 3.58 |
| market cap | 297818685 |
| price avg 50 | 6.8148 |
| price avg 200 | 5.20235 |
| exchange | NASDAQ |
| volume | 276285 |
| avg volume | 283834 |
| open | 9.85 |
| previous close | 9.89 |
| eps | -2.62 |
| pe | -3.84 |
| earnings announcement | 2025-02-25T13:30:00.000+0000 |
| shares outstanding | 29633700 |
| timestamp | 2025-01-17 21:00:00 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001333493 | |||
| revenue | 452871000 | 405356000 | 11.72 |
| gross profit | 451100000 | 403709000 | 11.74 |
| gross profit ratio | 1.0 | 1.0 | 0.02 |
| research and development expenses | 61027000 | 78809000 | -22.56 |
| operating expenses | 480174000 | 486806000 | -1.36 |
| interest income | 0 | 0 | NaN |
| interest expense | 10974000 | 42908000 | -74.42 |
| ebitda | -9158000 | -42373000 | 78.39 |
| ebitdaratio | -0.02 | -0.1 | 80.65 |
| operating income | -29074000 | -83097000 | 65.01 |
| operating income ratio | -0.06 | -0.2 | 68.68 |
| net income | -28214000 | -88722000 | 68.20 |
| net income ratio | -0.06 | -0.22 | 71.54 |
| eps | -2.37 | -3.24 | 26.85 |
Revenue Growth: revenue increased to 453 million in 2023 from 405 million in 2022 representing a change of 11.72%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 451 million in 2023 from 404 million in 2022 representing a change of 11.74%. This indicates a sales profitability growth, which is a positive sign for the company.
Operating Expenses: Operating Expenses decreased to 480 million in 2023 from 487 million in 2022 representing a change of -1.36%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to -9 million in 2023 from -42 million in 2022 representing a change of 78.39%. The increase in EBITDA indicates improved operational efficiency and profitability.
Earnings per Share (EPS): EPS increased to -2.37 in 2023 from -2.37 in 2022 representing a change of 26.85%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
Research and Development (R&D) Expenses: R&D Expenses decreased to 61 million in 2023 from 79 million in 2022 representing a change of -22.56%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.
Operating Income: Operating income decreased to -29 million in 2023 from -83 million in 2022 representing a change of 65.01%. The decrease in operating income indicates worse operational performance and decreased profitability.
Net Income: Net income decreased to -28 million in 2023 from -89 million in 2022 representing a change of 68.2%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001333493 | |||
| revenue | 58409000 | 65855999 | -11.31 |
| gross profit | 58409000 | 65855999 | -11.31 |
| gross profit ratio | 1 | 1 | 0.00 |
| research and development expenses | 0 | 13044000 | -100.00 |
| operating expenses | 101608000 | 90780000 | 11.93 |
| interest income | 0 | 0 | NaN |
| interest expense | 2859000 | 2849000 | 0.35 |
| ebitda | -39311000 | -20646000 | -90.40 |
| ebitdaratio | -0.67 | -0.31 | -114.68 |
| operating income | -43199000 | -24924000 | -73.32 |
| operating income ratio | -0.74 | -0.38 | -95.42 |
| net income | -42473000 | -27968000 | -51.86 |
| net income ratio | -0.73 | -0.42 | -71.22 |
| eps | -1.83 | -0.96 | -90.63 |
Revenue Growth: revenue decreased to 58 million in 2024Q3 from 66 million in 2024Q2 representing a change of -11.31%. This indicates a sales shrinking, which is a negative sign for the company.
Gross Profit: Gross Profit decreased to 58 million in 2024Q3 from 66 million in 2024Q2 representing a change of -11.31%. This indicates a sales profitability decline, which is a negative sign for the company.
Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2024Q3 from 13 million in 2024Q2 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.
Earnings per Share (EPS): EPS increased to -1.83 in 2024Q3 from -1.83 in 2024Q2 representing a change of -90.63%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
Operating Expenses: Operating Expenses decreased to 102 million in 2024Q3 from 91 million in 2024Q2 representing a change of 11.93%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to -39 million in 2024Q3 from -21 million in 2024Q2 representing a change of -90.4%. The increase in EBITDA indicates improved operational efficiency and profitability.
Operating Income: Operating income increased to -43 million in 2024Q3 from -25 million in 2024Q2 representing a change of -73.32%. The increase in operating income indicates better operational performance and increased profitability.
Net Income: Net income increased to -42 million in 2024Q3 from -28 million in 2024Q2 representing a change of -51.86%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001333493 | |||
| total assets | 1113345000 | 1112611000 | 0.07 |
| total liabilities | 209261000 | 198372000 | 5.49 |
| total equity | 904084000 | 876640000 | 3.13 |
| cash and cash equivalents | 115722000 | 144401000 | -19.86 |
| short term investments | 5930000 | 0 | NaN |
| long term investments | 0 | 3239000 | -100.00 |
| total current assets | 382352000 | 401084000 | -4.67 |
| total non current assets | 730993000 | 711527000 | 2.74 |
| total current liabilities | 78538000 | 60565000 | 29.68 |
| total non current liabilities | 130723000 | 137807000 | -5.14 |
| common stock | 41000 | 40000 | 2.50 |
| retained earnings | 7284000 | 73799000 | -90.13 |
| total debt | 103157000 | 106802000 | -3.41 |
Total Assets: Total Assets increased to 1,113 million in 2023 from 1,113 million in 2022 representing a change of 0.07%. Suggesting a growth in asset holdings.
Total Equity: Total Equity increased to 904 million in 2023 from 877 million in 2022 representing a change of 3.13%. This indicates an increase in shareholders' equity.
Short Term Investments: Short Term Investments increased to 6 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates an increase in short-term investment holdings.
Common Stock: Common Stock increased to 0 in 2023 from 0 in 2022 representing a change of 2.5%. This indicates an increase in ownership interest.
Total Debt: Total Debt decreased to 103 million in 2023 from 107 million in 2022 representing a change of -3.41%. This indicates a reduction in overall debt burden.
Total Liabilities: Total Liabilities increased to 209 million in 2023 from 198 million in 2022 representing a change of 5.49%. This indicates an increase in overall liabilities.
Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 116 million in 2023 from 144 million in 2022 representing a change of -19.86%. This indicates a decrease in available liquid assets.
Total Current Assets: Total Current Assets decreased to 382 million in 2023 from 401 million in 2022 representing a change of -4.67%. This indicates a worsen liquidity position.
Total Current Liabilities: Total Current Liabilities increased to 79 million in 2023 from 61 million in 2022 representing a change of 29.68%. This indicates a higher short-term debt burden.
Retained Earnings: Retained Earnings decreased to 7 million in 2023 from 74 million in 2022 representing a change of -90.13%. This indicates an accumulated losses.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001333493 | |||
| total assets | 1001991000 | 1038615000 | -3.53 |
| total liabilities | 175520000 | 172703000 | 1.63 |
| total equity | 826471000 | 865912000 | -4.55 |
| cash and cash equivalents | 64032000 | 126344000 | -49.32 |
| short term investments | 53750000 | 24721000 | 117.43 |
| long term investments | 0 | 0 | NaN |
| total current assets | 340867000 | 355852000 | -4.21 |
| total non current assets | 661124000 | 682763000 | -3.17 |
| total current liabilities | 53848000 | 116296000 | -53.70 |
| total non current liabilities | 121672000 | 373467000 | -67.42 |
| common stock | 43000 | 42000 | 2.38 |
| retained earnings | -113363000 | -59415000 | -90.80 |
| total debt | 98933000 | 100402000 | -1.46 |
Total Assets: Total Assets decreased to 1,002 million in 2024Q3 from 1,039 million in 2024Q2 representing a change of -3.53%. Suggesting a decrease in asset holdings.
Total Liabilities: Total Liabilities increased to 176 million in 2024Q3 from 173 million in 2024Q2 representing a change of 1.63%. This indicates an increase in overall liabilities.
Total Equity: Total Equity decreased to 826 million in 2024Q3 from 866 million in 2024Q2 representing a change of -4.55%. This indicates a decrease in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 64 million in 2024Q3 from 126 million in 2024Q2 representing a change of -49.32%. This indicates a decrease in available liquid assets.
Total Current Assets: Total Current Assets decreased to 341 million in 2024Q3 from 356 million in 2024Q2 representing a change of -4.21%. This indicates a worsen liquidity position.
Retained Earnings: Retained Earnings decreased to -113 million in 2024Q3 from -59 million in 2024Q2 representing a change of -90.8%. This indicates an accumulated losses.
Short Term Investments: Short Term Investments increased to 54 million in 2024Q3 from 25 million in 2024Q2 representing a change of 117.43%. This indicates an increase in short-term investment holdings.
Total Current Liabilities: Total Current Liabilities decreased to 54 million in 2024Q3 from 116 million in 2024Q2 representing a change of -53.7%. This indicates a lower short-term debt burden.
Common Stock: Common Stock increased to 0 in 2024Q3 from 0 in 2024Q2 representing a change of 2.38%. This indicates an increase in ownership interest.
Total Debt: Total Debt decreased to 99 million in 2024Q3 from 100 million in 2024Q2 representing a change of -1.46%. This indicates a reduction in overall debt burden.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001333493 | |||
| net change in cash | -28828000 | 62475000 | -146.14 |
| operating cash flow | -6692000 | -26869000 | 75.09 |
| free cash flow | -17471000 | -42375000 | 58.77 |
| capital expenditure | -10779000 | -15506000 | 30.48 |
| depreciation and amortization | 19916000 | 21108000 | -5.65 |
| deferred income tax | -2672000 | -18436000 | 85.51 |
| stock based compensation | 23213000 | 20316000 | 14.26 |
| accounts payables | 487000 | -7029000 | 106.93 |
| inventory | 0 | 0 | NaN |
| acquisitions net | 0 | 15506000 | -100.00 |
| investments in property plant and equipment | -2085999 | -15506000 | 86.55 |
| net cash used for investing activites | -15893000 | 25861000 | -161.46 |
| debt repayment | -38000 | 64726000 | -100.06 |
| common stock issued | 0 | 0 | NaN |
| common stock repurchased | -3330000 | -3102000 | -7.35 |
| dividends paid | -3533000 | 0 | NaN |
| net cash used provided by financing activities | -6224000 | 63838000 | -109.75 |
| cash at end of period | 118812000 | 147640000 | -19.53 |
| accounts receivables | -34955000 | 3118000 | -1221.07 |
| cash at beginning of period | 147640000 | 85165000 | 73.36 |
Net Change in Cash: Net Change in Cash decreased to -29 million in 2023 from 62 million in 2022 representing a change of -146.14%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.
Capital Expenditure: Capital Expenditure increased to -11 million in 2023 from -16 million in 2022 representing a change of 30.48%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Deferred Income Tax: Deferred Income Tax increased to -3 million in 2023 from -18 million in 2022 representing a change of 85.51%. This indicates that the company's tax liability for future periods has increased.
Stock-Based Compensation: Stock-Based Compensation increased to 23 million in 2023 from 20 million in 2022 representing a change of 14.26%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
Dividends Paid: Dividends Paid decreased to -4 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.
Operating Cash Flow: Operating Cash Flow increased to -7 million in 2023 from -27 million in 2022 representing a change of 75.09%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to -17 million in 2023 from -42 million in 2022 representing a change of 58.77%. This indicates an increase in cash generated after accounting for capital expenditures.
Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2023 from 7 million in 2022 representing a change of 106.93%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables decreased to -35 million in 2023 from 3 million in 2022 representing a change of -1221.07%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001333493 | |||
| operating cash flow | -29283000 | -32182000 | 9.01 |
| free cash flow | -33472000 | -35036000 | 4.46 |
| capital expenditure | -4189000 | -2854000 | -46.78 |
| depreciation and amortization | 3827000 | 4278000 | -10.54 |
| deferred income tax | -1709000 | -1249000 | -36.83 |
| stock based compensation | 4479000 | 5106000 | -12.28 |
| accounts receivables | 13204000 | 13826000 | -4.50 |
| accounts payables | 509000 | -1537000 | 133.12 |
| inventory | 0 | 0 | NaN |
| acquisitions net | 0 | 0 | NaN |
| investments in property plant and equipment | 5344000 | -2854000 | 287.25 |
| net cash used for investing activites | -32678000 | -13448000 | -143.00 |
| debt repayment | 0 | 0 | NaN |
| common stock issued | 0 | 0 | NaN |
| common stock repurchased | -450000 | -596000 | 24.50 |
| dividends paid | 0 | -2740000 | 100.00 |
| net cash used provided by financing activities | -450000 | -2982000 | 84.91 |
| net change in cash | -59222000 | -48642000 | -21.75 |
| cash at end of period | 67122000 | 126344000 | -46.87 |
| cash at beginning of period | 126344000 | 174986000 | -27.80 |
Net Change in Cash: Net Change in Cash decreased to -59 million in 2024Q3 from -49 million in 2024Q2 representing a change of -21.75%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to -29 million in 2024Q3 from -32 million in 2024Q2 representing a change of 9.01%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to -33 million in 2024Q3 from -35 million in 2024Q2 representing a change of 4.46%. This indicates an increase in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure decreased to -4 million in 2024Q3 from -3 million in 2024Q2 representing a change of -46.78%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Stock-Based Compensation: Stock-Based Compensation decreased to 4 million in 2024Q3 from 5 million in 2024Q2 representing a change of -12.28%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables decreased to 1 million in 2024Q3 from 2 million in 2024Q2 representing a change of 133.12%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables decreased to 13 million in 2024Q3 from 14 million in 2024Q2 representing a change of -4.5%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.
Dividends Paid: Dividends Paid increased to 0 million in 2024Q3 from -3 million in 2024Q2 representing a change of 100.0%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q3 2024 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2023-12-31 | 2022-12-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2023 | 2022 | NaN |
| revenue per share | 16.16 | 14.82 | 9.10 |
| net income per share | -1.01 | -3.24 | 68.95 |
| operating cash flow per share | -0.24 | -0.98 | 75.68 |
| free cash flow per share | -0.62 | -1.55 | 59.74 |
| cash per share | 4.34 | 5.28 | -17.73 |
| book value per share | 32.27 | 33.42 | -3.43 |
| tangible book value per share | 31.43 | 32.27 | -2.62 |
| shareholders equity per share | 32.27 | 33.42 | -3.43 |
| interest debt per share | 4.07 | 5.47 | -25.55 |
| market cap | 244299520.0 | 132417560 | 84.49 |
| enterprise value | 231734520.0 | 94818560 | 144.40 |
| pe ratio | -8.66 | -1.49 | -480.15 |
| price to sales ratio | 0.54 | 0.33 | 65.13 |
| pocfratio | -36.51 | -4.93 | -640.75 |
| pfcf ratio | -13.98 | -3.12 | -347.48 |
| pb ratio | 0.27 | 0.14 | 86.56 |
| ptb ratio | 0.27 | 0.14 | 86.56 |
| ev to sales | 0.51 | 0.23 | 118.76 |
| enterprise value over ebitda | -25.3 | -2.24 | -1030.80 |
| ev to operating cash flow | -34.63 | -3.53 | -881.28 |
| ev to free cash flow | -13.26 | -2.24 | -492.77 |
| earnings yield | -0.12 | -0.67 | 82.76 |
| free cash flow yield | -0.07 | -0.32 | 77.65 |
| debt to equity | 0.11 | 0.12 | -2.33 |
| debt to assets | 0.09 | 0.1 | -3.48 |
| net debt to ebitda | 1.37 | 0.89 | 54.62 |
| current ratio | 4.87 | 6.62 | -26.49 |
| interest coverage | -2.65 | -1.94 | -36.80 |
| income quality | 0.24 | 0.3 | -21.68 |
| dividend yield | 0.01 | 0 | NaN |
| payout ratio | -0.13 | 0 | NaN |
| sales general and administrative to revenue | 0.19 | 0.18 | 8.14 |
| research and ddevelopement to revenue | 0.13 | 0.19 | -30.69 |
| intangibles to total assets | 0.02 | 0.03 | -24.65 |
| capex to operating cash flow | -1.61 | -0.58 | -179.11 |
| capex to revenue | 0.02 | 0.04 | -37.78 |
| capex to depreciation | 0.54 | 0.73 | -26.32 |
| stock based compensation to revenue | 0.05 | 0.05 | 2.27 |
| graham number | 27.04 | 49.38 | -45.24 |
| roic | -0.03 | -0.07 | 60.45 |
| return on tangible assets | -0.03 | -0.08 | 68.45 |
| graham net net | 3.53 | 4.75 | -25.76 |
| working capital | 303814000 | 340519000 | -10.78 |
| tangible asset value | 880484000 | 882939000 | -0.28 |
| net current asset value | 173091000 | 202712000 | -14.61 |
| invested capital | 355045000 | 403836000 | -12.08 |
| average receivables | 247019000 | 252976500 | -2.35 |
| average payables | 6964500 | 10241000 | -31.99 |
| average inventory | 0.5 | 11431000.5 | -100.00 |
| days sales outstanding | 200.41 | 220.95 | -9.30 |
| days payables outstanding | 1483.29 | 1491.91 | -0.58 |
| days of inventory on hand | 0 | 0.0 | -100.00 |
| receivables turnover | 1.82 | 1.65 | 10.25 |
| payables turnover | 0.25 | 0.24 | 0.58 |
| inventory turnover | 0 | 1647000 | -100.00 |
| roe | -0.03 | -0.1 | 67.84 |
| capex per share | 0.38 | 0.57 | -32.12 |
ROE: Return on Equity (ROE) increased to -0.03 on 2023-12-31 from -0.10 on 2022-12-31, representing a change of 67.84%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -8.66 on 2023-12-31 from -1.49 on 2022-12-31, representing a change of -480.15%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio decreased to 4.87 on 2023-12-31 from 6.62 on 2022-12-31, representing a change of -26.49%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.11 on 2023-12-31 from 0.12 on 2022-12-31, representing a change of -2.33%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
| 2024-09-30 Q3 | 2024-06-30 Q2 | Q/Q change % | |
|---|---|---|---|
| EHTH | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 1.98 | 2.25 | -12.07 |
| net income per share | -1.44 | -0.96 | -50.56 |
| operating cash flow per share | -0.99 | -1.1 | 9.79 |
| free cash flow per share | -1.14 | -1.2 | 5.28 |
| cash per share | 3.99 | 5.17 | -22.70 |
| book value per share | 28.03 | 29.62 | -5.37 |
| tangible book value per share | 28.03 | 29.62 | -5.37 |
| shareholders equity per share | 28.03 | 29.62 | -5.37 |
| interest debt per share | 3.45 | 3.53 | -2.26 |
| market cap | 120298800 | 134471800 | -10.54 |
| enterprise value | 155199800 | 108529800 | 43.00 |
| pe ratio | -0.71 | -1.2 | 41.09 |
| price to sales ratio | 2.06 | 2.04 | 0.87 |
| pocfratio | -4.11 | -4.18 | 1.68 |
| pfcf ratio | -3.59 | -3.84 | 6.36 |
| pb ratio | 0.15 | 0.16 | -6.27 |
| ptb ratio | 0.15 | 0.16 | -6.27 |
| ev to sales | 2.66 | 1.65 | 61.23 |
| enterprise value over ebitda | -3.95 | -5.26 | 24.90 |
| ev to operating cash flow | -5.3 | -3.37 | -57.16 |
| ev to free cash flow | -4.64 | -3.1 | -49.68 |
| earnings yield | -0.35 | -0.21 | -69.75 |
| free cash flow yield | -0.28 | -0.26 | -6.79 |
| debt to equity | 0.12 | 0.12 | 3.24 |
| debt to assets | 0.1 | 0.1 | 2.14 |
| net debt to ebitda | -0.89 | 1.26 | -170.66 |
| current ratio | 6.33 | 3.06 | 106.88 |
| interest coverage | -15.11 | -8.75 | -72.72 |
| income quality | 0.69 | 1.15 | -40.08 |
| dividend yield | 0 | 0.02 | -100.00 |
| payout ratio | 0 | -0.1 | 100.00 |
| sales general and administrative to revenue | 0.35 | 0.34 | 2.16 |
| research and ddevelopement to revenue | 0 | 0.2 | -100.00 |
| intangibles to total assets | 0 | 0 | NaN |
| capex to operating cash flow | -0.14 | -0.09 | -61.31 |
| capex to revenue | 0.07 | 0.04 | 65.49 |
| capex to depreciation | 1.09 | 0.67 | 64.07 |
| stock based compensation to revenue | 0.08 | 0.08 | -1.10 |
| graham number | 30.14 | 25.25 | 19.36 |
| roic | -0.04 | -0.02 | -76.44 |
| return on tangible assets | -0.04 | -0.03 | -57.41 |
| graham net net | 18.9 | 20.63 | -8.41 |
| working capital | 287019000 | 239556000 | 19.81 |
| tangible asset value | 826471000 | 865912000 | -4.55 |
| net current asset value | 165347000 | 183149000 | -9.72 |
| invested capital | 304231000 | 257346000 | 18.22 |
| average receivables | 826478500 | 518738500 | 59.32 |
| average payables | 5182000 | 5622000 | -7.83 |
| average inventory | 0.5 | 0.5 | 0.00 |
| days sales outstanding | 1263.35 | 1138.47 | 10.97 |
| days payables outstanding | 0 | 0 | NaN |
| days of inventory on hand | 0 | 0 | NaN |
| receivables turnover | 0.07 | 0.08 | -9.88 |
| payables turnover | 0 | 0 | NaN |
| inventory turnover | 0 | 0 | NaN |
| roe | -0.05 | -0.03 | -59.11 |
| capex per share | 0.14 | 0.1 | 45.52 |
ROE: Return on Equity (ROE) decreased to -0.05 on 2024-09-30 Q3 from -0.03 on 2024-06-30 Q2, representing a change of -59.11%. Suggesting that the company has not been generating high returns for its shareholders.
Current Ratio: Current Ratio increased to 6.33 on 2024-09-30 Q3 from 3.06 on 2024-06-30 Q2, representing a change of 106.88%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to -0.71 on 2024-09-30 Q3 from -1.20 on 2024-06-30 Q2, representing a change of 41.09%. Indicating an increase in the relative valuation of the company's stock.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.12 on 2024-09-30 Q3 from 0.12 on 2024-06-30 Q2, representing a change of 3.24%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
None
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Positive
Publish Date: 2025-01-06 16:30:00
AUSTIN, Texas , Jan. 6, 2025 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH) ( ehealth.com ), a leading private online health insurance marketplace (the "Company"), today announced that on January 2, 2025, the Compensation Committee of its Board of Directors granted inducement stock unit awards to two new employees covering an aggregate of 13,000 shares of the Company's common stock. Each of these awards was granted under the Company's Amended and Restated 2021 Inducement Plan (the "Inducement Plan") and otherwise will be subject to the terms and conditions of a stock unit agreement under the Inducement Plan.
Sentiment: Positive
Publish Date: 2024-12-24 10:45:31
EHTH exceeds expectations in telephonic and online conversion rates and leverages strong consumer demand for its omnichannel platform.
Sentiment: Positive
Publish Date: 2024-12-17 11:55:53
eHealth, Inc. is an online health insurance marketplace with strong enrollment, particularly in Medicare plans, aided by new technologies and live assistance. Despite a 90%+ drop from its 2020 peak, Q3 2024 showed signs of improvement, with a 16% decline in acquisition costs and a 6% reduction in adjusted net loss. Significant growth in submitted Medicare applications and a new member retention program have led to raised revenue and profit guidance for 2024.
Sentiment: Positive
Publish Date: 2024-12-17 08:00:00
AUSTIN, Texas , Dec. 17, 2024 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today provided commentary on its Annual Enrollment Period (AEP) performance and updated guidance ranges for the fiscal year ending December 31, 2024. "This dynamic enrollment period was marked by significant changes to Medicare Advantage and Part D plan offerings, creating an increased demand for the trusted, carrier-agnostic solutions that eHealth provides to help beneficiaries navigate their coverage options.
Sentiment: Positive
Publish Date: 2024-11-19 09:00:00
eHealth research examines costs & trends midway through Medicare's Annual Enrollment Period and outlines beneficiaries' priorities for President-elect Trump AUSTIN, Texas , Nov. 19, 2024 /PRNewswire/ -- New original research from eHealth, Inc. (Nasdaq: EHTH), a leading online private health insurance marketplace, finds that the average premium for Medicare Part D drug plans selected by beneficiaries in the first half of Medicare's Annual Enrollment Period is up 17% from a year ago. Survey data included in eHealth's report show that 64% of Medicare beneficiaries are more confident in the future sustainability of Medicare based on the outcome of the presidential election.
Sentiment: Negative
Publish Date: 2024-11-18 12:15:39
EHTH's third-quarter results suffer from lower commissions and other revenues. Lower expenses partially offset the negatives.
Sentiment: Positive
Publish Date: 2024-11-13 09:00:00
Award-winning campaign features real Medicare beneficiaries saving on coverage with eHealth AUSTIN, Texas , Nov. 13, 2024 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH) (ehealth.com), a leading online private health insurance marketplace, announced today that the company's new brand identity, which is transforming how the industry markets to Medicare beneficiaries, has been selected by Modern Healthcare and Ad Age as a winner of a 2024 Silver Healthcare Marketing Impact Award for Integrated Campaign of the Year. The Healthcare Marketing Impact Awards recognizes outstanding marketing, advertising, and communication campaigns across all media platforms.
Sentiment: Neutral
Publish Date: 2024-11-12 18:33:00
AUSTIN, Texas , Nov. 12, 2024 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, announced that Fran Soistman, Chief Executive Officer, will participate in a fireside chat format presentation at the UBS Global Healthcare Conference today on Tuesday, November 12th, 2024, at 4:15 p.m. Pacific Time.
Sentiment: Positive
Publish Date: 2024-11-06 12:22:07
eHealth, Inc. (NASDAQ:EHTH ) Q3 2024 Earnings Conference Call November 6, 2024 8:30 AM ET Company Participants Eli Newbrun-Mintz - Senior Investor Relations Manager Francis Soistman - Chief Executive Officer John Stelben - Chief Financial Officer Conference Call Participants George Sutton - Craig-Hallum Operator Please stand by. Your program is about to begin.
Sentiment: Negative
Publish Date: 2024-11-06 09:46:17
EHealth (EHTH) came out with a quarterly loss of $1.86 per share versus the Zacks Consensus Estimate of a loss of $1.13. This compares to loss of $1.54 per share a year ago.
Sentiment: Positive
Publish Date: 2024-11-06 07:30:00
AUSTIN, Texas , Nov. 6, 2024 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the third quarter ended September 30, 2024. Please click the PDF link to access the full earnings press release: The earnings press release and earnings presentation can also be accessed on the eHealth Investor Relations website at https://ir.ehealthinsurance.com.
Sentiment: Positive
Publish Date: 2024-10-30 09:00:00
Ten years after full ACA implementation, eHealth report highlights gap between enrollees who receive subsidies and those who don't AUSTIN, Texas , Oct. 30, 2024 /PRNewswire/ -- The Affordable Care Act (ACA) was fully implemented ten years ago in 2014, but with open enrollment just around the corner, enrollees are split on the law's success, according to original research released today by eHealth Inc. (Nasdaq: EHTH) (eHealth.com), a leading online private health insurance marketplace. In a poll of more than 300 ACA plan enrollees, eHealth found a significant divide between those who receive government subsidies and those who do not.
Sentiment: Positive
Publish Date: 2024-10-29 16:15:00
AUSTIN, Texas , Oct. 29, 2024 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced that Fran Soistman, Chief Executive Officer, will participate in investor meetings at the UBS Global Healthcare Conference on Tuesday, November 12th, 2024. For additional information about the conference or to schedule a one-on-one meeting with eHealth management, please reach out to your UBS representative or eHealth's investor relations contact.
Sentiment: Positive
Publish Date: 2024-10-28 09:00:00
Certification validates that eHealth is utilizing leading security practices to protect sensitive information AUSTIN, Texas , Oct. 28, 2024 /PRNewswire/ --Â Today eHealth, Inc. (Nasdaq: EHTH) (eHealth.com), a leading online private health insurance marketplace, is pleased to announce that it has successfully achieved HITRUST i1 certification for its carrier integration platform hosted through Amazon Web Services, marking a significant milestone in the company's ongoing commitment to uphold the highest standards of information security and compliance in the healthcare industry. "This certification underscores our dedication to safeguarding sensitive healthcare data,"Â said Ketan Babaria, Chief Digital Officer at eHealth.
Sentiment: Neutral
Publish Date: 2024-10-22 16:15:00
AUSTIN, Texas , Oct. 22, 2024 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced that the company plans to release third quarter 2024 financial results on November 6, 2024. The company will hold an earnings conference call beginning at 8:30 a.m.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
